Clinical Trials Directory

Trials / Completed

CompletedNCT05036265

Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM

Laparoscopic Liver Resection for Colorectal Liver Metastases: Retrospective Analysis of Prognostic Factors and Oncological Outcomes in a Single-center Cohort

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
General Hospital Groeninge · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Laparoscopic liver resection (LLR) has gained acceptance as an effective treatment for colorectal liver metastases (CRLM) in selected patients, providing similar oncologic outcomes compared to open liver resection (OLR). A single-center retrospective analysis of a prospectively maintained database was performed. The primary aim of this study was to determine prognostic factors for the survival outcomes associated with LLR for CRLM.

Detailed description

LLR was defined as pure LLR, including conversions to OLR. In case of missing data, additional details were retrieved from the individual patient file. Data on patient demographics, timing of diagnosis, neoadjuvant chemotherapy (NAC), tumor characteristics (both primary tumor and CRLM), histopathology, molecular characteristics, operative technique (including classification into anatomically major/technically major/minor LR), intra- and postoperative course, adjuvant chemotherapy (AC) as well as oncological outcomes (OS and DFS) were gathered and analyzed. Postoperative complications were graded according to the Clavien-Dindo classification. Complications were classified as major in case of Clavien-Dindo ≥ 3A.

Conditions

Timeline

Start date
2011-09-01
Primary completion
2020-03-15
Completion
2021-08-05
First posted
2021-09-05
Last updated
2021-09-05

Source: ClinicalTrials.gov record NCT05036265. Inclusion in this directory is not an endorsement.